Effects of fermented pueraria radix by Lactobacillus acidophilus on lipid and bone metabolism in ovariectomized rats

Asian Journal of Animal and Veterinary Advances

Volumn 9, Issue 9, 2014, Pages 556-567

  Hong, Go Eun ^a   Pyun, Chang Won ^a   Jeong, Sang Min ^a   Han, Kyu Ho ^b   Lee, Chi Ho ^a  

^a Konkuk University   (South Korea)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Fermentation; Lactobacillus acidophilus; Ovariectomized rat; Pueraria radix

Indexed keywords

EID: 84906556817     PISSN: 16839919     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajava.2014.556.567     Document Type: Article

References (40)

1. AOAC, 2005. Official Methods Analysis. 18th Edn., Association of Official Analytical Chemists, Washington, DC., USA., pp: 125-132.
2. Atkinson, C., C. L. Frankenfeld and J. W. Lampe, 2005. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp. Biol. Med., 230: 155-170.
3. Babaei, P., R. Mehdizadeh, M. M. Ansar and A. Damirchi, 2010. Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats. Menopause Int., 16: 100-104.
4. Bebrevska, L., K. Foubert, N. Hermans, S. Chatterjee and E. Van Marck et al., 2010. In vivo antioxidative activity of a quantified Pueraria lobata root extract. J. Ethnopharmacol., 127: 112-117.
5. Boue, S. M., T. E. Wiese, S. Nehls, M. E. Burow and S. Elliott et al., 2003. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J. Agric. Food Chem., 51: 2193-2199.
6. Bush, T. L. and E. Barrett-Connor, 1985. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol. Rev., 7: 80-104.
7. Cho, H. J., H. J. Jun, J. H. Lee, Y. Jia and M. H. Hoang et al., 2012. Acute effect of High-dose Isoflavones from Pueraria lobata (Willd.) ohwi on lipid and bone metabolism in ovariectomized mice. Phytother. Res., 26: 1864-1871.
8. Cummings, S. R., D. Bates and D. M. Black, 2002. Clinical use of bone densitometry: Scientific review. JAMA, 288: 1889-1897.
9. Draper, C. R., M. J. Edel, I. M. Dick, A. G. Randall, G. B. Martin and R. L. Prince, 1997. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr., 127: 1795-1799.
10. Frolik, C. A., H. U. Bryant, E. C. Black, D. E. Magee and S. Chandrasekhar, 1996. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene HCl, tamoxifen, estrogen and alendronate. Bone, 18: 621-627.
11. Guerra, M. C., E. Speroni, M. Broccoli, M. Cangini and P. Pasini et al., 2000. Comparison between Chinese medical herb Pueraria lobatacrude extract and its main isoflavone puerarin: Antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci., 67: 2997-3006.
12. Holder, C. L., M. I. Churchwell and D. R. Doerge, 1999. Quantification of soy isoflavones, genistein and daidzein and conjugates in rat blood using LC/ES-MS. J. Agric. Food Chem., 47: 3764-3770.
13. Hong, G. E., C. W. Pyun, S. K. Kim, K. H. Han, C. Y. Yang and C. H. Lee, 2012. Effects of fermented black soybean pulp on lipid and bone metabolism in ovariectomized rats. Food Sci. Biotechnol., 21: 1397-1403.
14. Hong, G. E., P. K. Mandal, C. W. Pyun, K. Choi and S. K. Kim et al., 2009. Isoflavone aglycone from fermented soy pulp prevents osteoporosis in ovariectomized rats. Asian J. Anim. Vet. Adv., 4: 288-296.
15. Hong, G. E., P. K. Mandal, K. W. Lim and C. H. Lee, 2012. Fermentation increases isoflavone aglycone contents in black soybean pulp. Asian J. Animal Vet. Adv., 7: 502-511.
16. Izumi, T., M. K. Piskula, S. Osawa, A. Obata and K. Tobe et al., 2000. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr., 130: 1695-1699.
17. Jeon, B. J., J. Ahn and H. S. Kwak, 2009. Effect of Isoflavone-enriched milk on bone mass in ovariectomized rats. J. Med. Food, 12: 1260-1267.
18. Kalu, D. N., B. H. Arjmandi, C. C. Liu, M. A. Salih and R. S. Birnbaum, 1994. Effects of ovariectomy and estrogen on the serum levels of Insulin-like growth Factor-I and Insulin-like growth factor binding protein-3. Bone Mineral, 25: 135-148.
19. Kaya, M., J. Ito, A. Kotaka, K. Matsumura and H. Bando et al., 2008. Isoflavone aglycones production from isoflavone glycosides by display of β-glucosidase from Aspergillus oryzae on yeast cell surface. Applied Microbiol. Biotechnol., 79: 51-60.
20. Keung, W. M. and B. L. Vallee, 1993. Daidzin: A potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc. Natl. Acad. Sci. USA., 90: 1247-1251.
21. Kim, D. H., K. U. Yu, E. A. Bae and M. J. Han, 1998. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. Biol. Pharm. Bull., 21: 628-630.
22. Kinjo, J., R. Tsuchihashi, K. Morito, T. Hirose and T. Aomori et al., 2004. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol. Pharm. Bull., 27: 185-188.
23. Lee, Y. B., H. J. Lee, K. S. Kim, J. Y. Lee, S. Y. Nam, S. H. Cheon and H. S. Sohn, 2004. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem., 68: 1040-1045.
24. Lian, J. B. and C. M. Gundberg, 1988. Osteocalcin. Biochemical considerations and clinical applications. Clin. Orthop. Relat. Res., 226: 267-291.
25. Naaz, A., S. Yellayi, M. A. Zakroczymski, D. Bunick and D. R. Doerge et al., 2003. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology, 144: 3315-3320.
26. Okabe, Y., T. Shimazu and H. Tanimoto, 2011. Higher bioavailability of isoflavones after a single ingestion of Aglycone-rich fermented soybeans compared with Glucoside-rich non-fermented soybeans in Japanese postmenopausal women. J. Sci. Food Agric., 91: 658-663.
27. Okazaki, R., D. Inoue, M. Shibata, M. Saika and S. Kido et al., 2002. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express Estrogen Receptor (ER) α or β. Endocrinology, 143: 2349-2356.
28. Pan, Y., 2007. Effects of isoflavones on body fat accumulation in neutered male and female dogs. FASEB J., 21: 551-560.
29. Saloniemi, H., K. Wahala, P. Nykanen-Kurki, K. Kallela and I. Saastamoinen, 1995. Phytoestrogen content and estrogenic effect of legume fodder. Exp. Biol. Med., 208: 13-17.
30. Silva, M. J. and L. J. Gibson, 1997. Modeling the mechanical behavior of vertebral trabecular bone: Effects of Age-related changes in microstructure. Bone, 21: 191-199.
31. Sitara, D., M. S. Razzaque, M. Hesse, S. Yoganathan, T. Taguchi, R. G. Erben and B. Lanske, 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol., 23: 421-432.
32. Son, G. S., 2006. Effect of soybean intake on bone mineral density and bone turnover markers in postmenopausal women. Taehan Kanho Hakhoe Chi, 36: 933-941.
33. Suetsugi, M., L. Su, K. Karlsberg, Y. C. Yuan and S. Chen, 2003. Flavone and isoflavone phytoestrogens are agonists of Estrogen-related receptors. Mol. Cancer Res., 1: 981-991.
34. Szkudelska, K., L. Nogowski and T. Szkudelski, 2000. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J. Steroid. Biochem. Mol. Biol., 75: 265-271.
35. Taku, K., K. Umegaki, Y. Sato, Y. Taki, K. Endoh and S. Watanabe, 2007. Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr., 85: 1148-1156.
36. Tyagi, A. M., K. Srivastava, K. Sharan, D. Yadav, R. Maurya and D. Singh, 2011. Daidzein prevents the increase in CD4+ CD28null T cells and B lymphopoesis in ovariectomized mice: A key mechanism for Anti-osteoclastogenic effect. PLoS One, Vol. 6. 10. 1371/journal. pone. 0021216
37. Wang, P. P., X. F. Zhu, L. Yang, H. Liang, S. W. Feng and R. H. Zhang, 2012. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK and Wnt/β-catenin pathways. J. Asian Nat. Prod. Res., 14: 897-905.
38. Wang, Q., T. Wu, X. Chen, X. Duan and J. Zheng et al., 2006. Puerarin injection for unstable angina pectoris. Cochrane Database Syst. Rev. 10. 1002/14651858. CD004196. pub2
39. Wang, W., Y. Tanaka, Z. Han and C. M. Higuchi, 1995. Proliferative response of mammary glandular tissue to formononetin. Nutr. Cancer, 23: 131-140.
40. Zeng, C. Y., L. Y. Zhang, Y. P. Zhou and L. L. Fan, 1982. Pharmacological studies on Pueraria radix. Clin. Med., 95: 145-150.